Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents

被引：37

作者：

Britton, Robert G. ^{[2
]}

Horner-Glister, Emma ^{[1
]}

Pomenya, Odette A. ^{[1
]}

Smith, Ewan E. ^{[3
]}

Denton, Roanne ^{[3
]}

Jenkins, Paul R. ^{[3
]}

Steward, William P. ^{[1
]}

Brown, Karen ^{[1
]}

Gescher, Andreas ^{[1
]}

Sale, Stewart ^{[1
]}

机构：

[1] Univ Leicester, Leicester Royal Infirm, RKCSB, Dept Canc Studies & Mol Med, Leicester LE2 7LX, Leics, England

[2] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 7RH, Leics, England

[3] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 54卷

关键词：

Flavonols; AR signalling pathway; Prostate cancer management; CELL-CYCLE ARREST; ANDROGEN RECEPTOR; QUERCETIN; APOPTOSIS; EXPRESSION; EFFICACY; FISETIN; LINES;

D O I：

10.1016/j.ejmech.2012.06.031

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A library of flavonol analogues was synthesised and evaluated as potential anticancer agents against a human prostate cancer cell line, 22rv1. Compounds 3, 8 and 11 (IC50 2.6, 3.3 and 4.0 mu M respectively) showed potent cancer cell growth inhibition, comparable to the lead compound 3',4',5'-trimethoxyflavonol (1) (IC50 3.1 mu M) and superior to the naturally occurring flavonols quercetin (16) and fisetin (22) (both >15 mu M). Results indicate that the 3',4',5'- arrangement of either hydroxy (OH) or methoxy (OMe) residues is important for growth arrest of these cells and that the OMe analogues may be superior to their OH counterparts. Compounds 1, 3, 8 and 11 warrant further investigation as potential agents for the management of prostate cancer. (C) 2012 Elsevier Masson SAS. All rights reserved.

引用

页码：952 / 958

页数：7

共 50 条

[1] Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents
Chen, Hong
Yu, Yu-Zhong
Tian, Xiu-Mei
Wang, Cai-Lu
Qian, Yu-Na
Deng, Zai-An
Zhang, Jing-Xiao
Lv, Dao-Jun
Zhang, Hai-Bo
Shen, Jian-Liang
Yuan, Mu
Zhao, Shan-Chao
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (01) : 133 - 143
[2] Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents
Shi, Yun-Kai
Wang, Bo
Shi, Xiao-Li
Zhao, Yuan-Di
Yu, Bin
Liu, Hong-Min
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 145 : 11 - 22
[3] Design, Synthesis and Biological Evaluation of Thiohydantoin Derivatives as Novel Anti-prostate Cancer Agents
Liu, Jianzhen
Liu, Bo
Jing, Yongkui
Zhao, Guisen
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (06) : 740 - 746
[4] Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents
Rudovich, Anton S.
Perina, Miroslav
Krech, Anastasiya, V
Novozhilova, Maria Y.
Tumilovich, Anastasia M.
Shkel, Tatyana, V
Grabovec, Irina P.
Kvasnica, Miroslav
Mada, Lukas
Zavialova, Maria G.
Mekhtiev, Arif R.
Jorda, Radek
Zhabinskii, Vladimir N.
Khripach, Vladimir A.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
[5] Synthesis and biological evaluation of 17-cyanopyridine derivatives of pregnenolone as potential anti-prostate cancer agents
Sun, Yingying
Gao, Peipei
Zhu, Li
Li, Zhaoxiang
Zhao, Ruiyun
Li, Congyu
Shan, Lihong
STEROIDS, 2021, 171
[6] Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents
Almahmoud, Suliman
Elix, Catherine C.
Jones, Jeremy O.
Hopkins, Corey R.
Vennerstrom, Jonathan L.
Zhong, Haizhen A.
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 46
[7] Synthesis and evaluation of linear furanocoumarins as potential anti-breast and anti-prostate cancer agents
Siddheshwar K. Chauthe
Shivani Mahajan
Mahesh Rachamalla
Kulbhushan Tikoo
Inder P. Singh
Medicinal Chemistry Research, 2015, 24 : 2476 - 2484
[8] Synthesis and evaluation of linear furanocoumarins as potential anti-breast and anti-prostate cancer agents
Chauthe, Siddheshwar K.
Mahajan, Shivani
Rachamalla, Mahesh
Tikoo, Kulbhushan
Singh, Inder P.
MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (06) : 2476 - 2484
[9] Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors
Li, Kun
Li, Ying
Zhou, Di
Fan, Yinbo
Guo, Hongye
Ma, Tianyi
Wen, Jiachen
Liu, Dan
Zhao, Linxiang
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (08) : 1889 - 1897
[10] Design, Synthesis and Biological Evaluation of Novel 1, 3-thiazolidine-2, 4-diones as Anti-prostate Cancer Agents
Elancheran, Ramakrishnan
Saravanan, Kuppusamy
Divakar, Selvaraj
Kumari, Sima
Maruthanila, V. Lenin
Kabilan, Senthamarikannan
Ramanathan, Muthiah
Devi, Rajlakshmi
Kotoky, Jibon
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (13) : 1756 - 1768

← 1 2 3 4 5 →